Cargando…
The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID‐19
Comorbidities such as hypertension could exacerbate symptoms of coronaviral disease 2019 (COVID)‐19 infection. Patients with hypertension may receive both anti‐COVID‐19 and antihypertension therapies when infected with COVID‐19. However, it is not clear how different classes of anti‐hypertension dru...
Autores principales: | Zhao, Liyang, Li, Yusi, Yi, Wenjuan, Yan, Kuo, Yang, Chao, Radhakrishnan, Sridhar, Li, Rui, Tan, Ruirong, Fan, Gang, Dai, Mengyuan, Liu, Miao, Shao, Ning‐Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347732/ https://www.ncbi.nlm.nih.gov/pubmed/35656698 http://dx.doi.org/10.1002/jmv.27914 |
Ejemplares similares
-
Targeted Protein Degradation: An Important Tool for Drug Discovery
for “Undruggable” Tumor Transcription Factors
por: Dai, Mengyuan, et al.
Publicado: (2022) -
Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
por: Li, Gang, et al.
Publicado: (2020) -
The correlation between different antihypertensive treatments and prognosis of cardiovascular disease in hypertensive patients
por: Liu, Shengnan, et al.
Publicado: (2023) -
Safety and Efficacy of a New Renal Denervation Catheter in Hypertensive Patients in the Absent of Antihypertensive Medications: A Pilot Study
por: Li, Yang, et al.
Publicado: (2019) -
Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)